× |
|
WYNZORA (betamethasone dipropionate; calcipotriene) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
HYDROXYPROPYL CELLULOSE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
ZAVZPRET (zavegepant hydrochloride) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
BALCOLTRA (ethinyl estradiol; levonorgestrel) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
DESCOVY (emtricitabine; tenofovir alafenamide fumarate) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
DEFENCATH (heparin sodium; taurolidine) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
POVIDONE K25 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
VEMLIDY (tenofovir alafenamide fumarate) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
WINLEVI (clascoterone) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
VOCABRIA (cabotegravir sodium) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
STRAWBERRY Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
POVIDONE K29/32 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
BYETTA (exenatide synthetic) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
VANILLIN Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
HYPROMELLOSE 2910 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
HYPROMELLOSE 2208 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|